Xavier Badía

1.3k total citations
71 papers, 808 citations indexed

About

Xavier Badía is a scholar working on Economics and Econometrics, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xavier Badía has authored 71 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Economics and Econometrics, 10 papers in Surgery and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xavier Badía's work include Health Systems, Economic Evaluations, Quality of Life (27 papers), Pharmaceutical Economics and Policy (16 papers) and Pharmaceutical studies and practices (7 papers). Xavier Badía is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (27 papers), Pharmaceutical Economics and Policy (16 papers) and Pharmaceutical studies and practices (7 papers). Xavier Badía collaborates with scholars based in Spain, Canada and United Kingdom. Xavier Badía's co-authors include Rafael Dal‐Ré, Manuel Garcı́a-Losa, David Castro‐Díaz, Montserrat Espuña, Luis Prieto, Juan del Llano, Montserrat Roset, Hanane Khoury, Mireille Goetghebeur and Àlex Roca‐Cusachs and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Xavier Badía

65 papers receiving 782 citations

Peers

Xavier Badía

UROLO

RHEUM

PRM

EPIDE

Jason Yeaw United States

Carlos Crespo Spain

Patrick Mollon United States

Jathin Bandari United States

O. Karim United Kingdom

Su‐Chiu Chen Taiwan

Jalil Hosseini Iran

Jameel Nazir United Kingdom

Arnold Degboe United States

Saxon D. Smith Australia

Jason Yeaw United States

Xavier Badía

130 ×0.6

109 ×0.6

UROLO

203 ×1.3

RHEUM

37 ×0.3

PRM

113 ×1.1

EPIDE

Citations per year, relative to Xavier Badía Xavier Badía (= 1×) peers Jason Yeaw

Countries citing papers authored by Xavier Badía

Since Specialization

Citations

This map shows the geographic impact of Xavier Badía's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Badía with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Badía more than expected).

Fields of papers citing papers by Xavier Badía

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Badía. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Badía. The network helps show where Xavier Badía may publish in the future.

Co-authorship network of co-authors of Xavier Badía

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Badía. A scholar is included among the top collaborators of Xavier Badía based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Badía. Xavier Badía is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Badía, Xavier, et al.. (2024). Value contribution of etranacogene dezaparvovec gene therapy in moderately severe and severe haemophilia B through multi‐criteria decision analysis. Haemophilia. 30(6). 1281–1287. 1 indexed citations

González‐Meneses, Antonio, et al.. (2023). Contribución de valor de olipudase alfa en el tratamiento de las manifestaciones no relacionadas con el SNC del déficit de esfingomielinasa ácida mediante análisis de decisión multicriterio. 42(1). 1 indexed citations

Poveda, José Luís, et al.. (2023). ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requiring a PASS would be more likely to be reimbursed in Spain. Orphanet Journal of Rare Diseases. 18(1). 4–4. 1 indexed citations

González‐Meneses, Antonio, et al.. (2023). Value contribution of olipudase alfa therapy for the management of the non-CNS manifestations of acid sphingomyelinase deficiency by multi-criteria decision analysis. 42(1). 1 indexed citations

Cantón, Rafael, et al.. (2020). Determining the burden of infectious diseases caused by carbapenem-resistant gram-negative bacteria in Spain. Enfermedades Infecciosas y Microbiología Clínica. 39(4). 179–183. 9 indexed citations

Badía, Xavier, et al.. (2019). Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut). Orphanet Journal of Rare Diseases. 14(1). 157–157. 43 indexed citations

Román, María, et al.. (2019). Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis. SHILAP Revista de lepidopterología. 6(1). 4 indexed citations

Poveda, José Luís, et al.. (2018). PSY155 - DETERMINING THE VALUE OF EMICIZUMAB (HEMLIBRA®) FOR THE PROPHYLAXIS TREATMENT OF HAEMOPHILIA A PATIENTS WITH INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA). Value in Health. 21. S462–S463. 1 indexed citations

Badía, Xavier, et al.. (2018). PHP169 - MCDA EVIDEM REFERENCE VALUE FRAMEWORK FOR DRUG EVALUATION AND DECISION MAKING IN SPAIN. Value in Health. 21. S179–S179. 12 indexed citations

10.

Badía, Xavier, et al.. (2017). Application Of Multi-Criteria Decision Analysis (MCDA) To Determine The Value Of Treatments For The Moderate To Severe Plaque Psoriasis In Spain. Value in Health. 20(9). A564–A564. 3 indexed citations

11.

Wagner, Monika, Hanane Khoury, Liga Bennetts, et al.. (2017). Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA. BMC Cancer. 17(1). 272–272. 32 indexed citations

12.

Badía, Xavier, et al.. (2016). CAN THE ETHICAL DILEMMAS FOR HEALTH CARE DECISION MAKING ON DRUG REIMBURSMENT BE TACKLED THROUGH HOLISTIC MCDA: AN ADAPTATION OF THE EVIDEM FRAMEWORK IN REAL-WORLD SETTING - THE CATALAN EXPERIENCE. Value in Health. 19(3). A264–A264. 1 indexed citations

13.

Torrent-Farnell, Josep, et al.. (2016). HT5 Development of a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision-Making in Catalonia (Spain): Pilot Study Focused in Orphan Drugs. Value in Health. 19(7). A353–A353. 2 indexed citations

14.

Espín, Jaime, et al.. (2016). Multi-Criteria Decision Analysis (MCDA): Common Tools for Different Needs Supporting Healthcare Decision Making in Spain. Value in Health. 19(7). A489–A490. 7 indexed citations

15.

Wagner, Monika, Hanane Khoury, Liga Bennetts, et al.. (2015). Appraising the Value of Lenvatinib for Radio-Iodine Refractory Differentiated Thyroid Cancer (Rr-Dtc): A Multi-Country Study Applying Holistic Multicriteria Decision Analysis (Mcda). Value in Health. 18(7). A477–A478. 4 indexed citations

16.

Carbonell, Jordi & Xavier Badía. (2008). Expectativas, preferencias y satisfacción de los pacientes con artritis reumatoide en tratamiento con infliximab. Medicina Clínica. 131(13). 493–499. 8 indexed citations

17.

Perona, Mónica, Fermín Mearin, M. Guilera, et al.. (2008). Cuestionario específico de calidad de vida para pacientes con estreñimiento: desarrollo y validación del CVE-20. Medicina Clínica. 131(10). 371–377. 6 indexed citations

18.

Carbonell, Jordi & Xavier Badía. (2006). Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide. Reumatología Clínica. 2(3). 137–145. 8 indexed citations

19.

Roca‐Cusachs, Àlex, et al.. (2001). Relation between clinical and therapeutic variables and quality of life in hypertension. Journal of Hypertension. 19(10). 1913–1919. 47 indexed citations

20.

Badía, Xavier, et al.. (1998). La medición del estado de salud en rehabilitación. ¿Capacidad funcional o calidad de vida?. Rehabilitación. 32(5). 291–294. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact